59
Views
5
CrossRef citations to date
0
Altmetric
Patent Evaluations

Imidazo[2,1-b]thiazoles and their use as pharmaceuticals

Sanofi-Aventis EP 1 923 062 A1 (equivalent to WO2008058641)

, PhD
Pages 369-371 | Published online: 27 Mar 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hossein Heli, Siamak Mirtorabi & Khashayar Karimian. (2011) Advances in iron chelation: an update. Expert Opinion on Therapeutic Patents 21:6, pages 819-856.
Read now

Articles from other publishers (4)

Ibrahim A. Alaraidh, Mohammad K. Okla, Saudi A. Alamri, Abdullah A. AL‐ghamdi, Walid H. Soufan, Ahmed A. Allam, Moustafa M. G. Fouda & Hatem E. Gaffer. (2019) Synthesis of Bis‐(2‐thiazolyl)amine Analogues and Evaluation of Their Antibacterial, Antioxidant and Cytotoxic Activities. ChemistrySelect 4:40, pages 11726-11734.
Crossref
Farshid Salimi, Hajar Sahebalzamani, Masume Maleki & Behrouz Notash. (2011) N , N ′-Bis(1,3-thiazol-2-yl)methylenediamine . Acta Crystallographica Section E Structure Reports Online 67:12, pages o3320-o3320.
Crossref
Marcin Jasiński, Grzegorz Mlostoń & Heinz Heimgartner. (2010) Synthesis of 2,3‐dihydroimidazo[2,1‐ b ]thiazole derivatives via cyclization of N ‐allylimidazoline‐2‐thiones . Journal of Heterocyclic Chemistry 47:6, pages 1287-1293.
Crossref
Kim Potgieter, Peter Mayer, Eric Hosten & Thomas I. A. Gerber. (2010) 2-[5-(Benzo[ d ]thiazol-2-yl)thiophen-2-yl]benzo[ d ]thiazole . Acta Crystallographica Section E Structure Reports Online 66:3, pages o531-o531.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.